Free tool
Stocks listed on Copenhagen
We cover 39 companies listed on Copenhagen. The median market value in the group is $7.23B. Across the group, the median move over the past trading day is +0.53%. 64% of the 39 with a 200-day average trade above it. Price change over the past year runs from −19.6% to +57.9% across the middle 80 percent of the group, with a median of +12.8%. Across the group, 4 companies currently carry a tier A volume signal.
Other lists in this group
Table
39 of 568 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| NOVO-B.CO | Novo Nordisk A/S | $212.57B | Mega cap | −13.21% |
| NDA-DK.CO | Nordea Bank Abp | $69.19B | Large cap | +32.25% |
| DSV.CO | DSV A/S | $52.21B | Large cap | −2.78% |
| MAERSK-B.CO | A.P. Møller - Mærsk A/S | $49.77B | Large cap | +70.98% |
| MAERSK-A.CO | A.P. Møller - Mærsk A/S | $47.85B | Large cap | +65.31% |
| DANSKE.CO | Danske Bank A/S | $46.94B | Large cap | +54.06% |
| NSIS-B.CO | Novozymes A/S | $33.21B | Large cap | +12.75% |
| VWS.CO | Vestas Wind Systems A/S | $32.34B | Large cap | +63.74% |
| ORSTED.CO | Ørsted A/S | $28.80B | Large cap | −28.35% |
| CARL-A.CO | Carlsberg A/S | $22.91B | Large cap | +22.92% |
| GMAB.CO | Genmab A/S | $21.08B | Large cap | +33.08% |
| CARL-B.CO | Carlsberg A/S | $18.14B | Large cap | +19.78% |
| COLO-B.CO | Coloplast A/S | $16.31B | Large cap | −20.81% |
| TRYG.CO | Tryg A/S | $14.46B | Large cap | −4.79% |
| PNDORA.CO | Pandora A/S | $9.60B | Mid cap | −6.04% |
| JYSK.CO | Jyske Bank A/S | $9.46B | Mid cap | +59.36% |
| DEMANT.CO | Demant A/S | $9.37B | Mid cap | +17.33% |
| ALSYDB.CO | AL Sydbank A/S | $8.66B | Mid cap | +35.59% |
| NKT.CO | NKT A/S | $7.76B | Mid cap | +53.78% |
| ALK-B.CO | ALK-Abelló A/S | $7.23B | Mid cap | +8.24% |
| ISS.CO | ISS A/S | $7.08B | Mid cap | +57.54% |
| ROCK-A.CO | Rockwool A/S | $7.07B | Mid cap | −8.88% |
| ROCK-B.CO | Rockwool A/S | $6.78B | Mid cap | −13.69% |
| KBHL.CO | Københavns Lufthavne A/S | $6.69B | Mid cap | −16.87% |
| HLUN-B.CO | H. Lundbeck A/S | $6.61B | Mid cap | +5.61% |
| RILBA.CO | Ringkjøbing Landbobank A/S | $6.58B | Mid cap | +20.71% |
| HLUN-A.CO | H. Lundbeck A/S | $6.55B | Mid cap | +26.06% |
| FLS.CO | FLSmidth & Co. A/S | $4.98B | Mid cap | +40.31% |
| ALMB.CO | Alm. Brand A/S | $3.66B | Mid cap | −2.28% |
| ZEAL.CO | Zealand Pharma A/S | $3.48B | Mid cap | −27.05% |
| TRMD-A.CO | TORM plc | $3.25B | Mid cap | +54.45% |
| RBREW.CO | Royal Unibrew A/S | $3.22B | Mid cap | −4.69% |
| AMBU-B.CO | Ambu A/S | $3.20B | Mid cap | −19.61% |
| SCHO.CO | Aktieselskabet Schouw & Co. | $2.62B | Mid cap | +29.95% |
| BAVA.CO | Bavarian Nordic A/S | $2.58B | Mid cap | −10.13% |
| PAAL-B.CO | Per Aarsleff Holding A/S | $2.28B | Mid cap | +11.56% |
| NETC.CO | Netcompany Group A/S | $2.19B | Mid cap | +26.66% |
| GN.CO | GN Store Nord A/S | $2.15B | Mid cap | −19.72% |
| EMBLA.CO | Embla Medical hf | $2.00B | Mid cap | −5.76% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.